NDC 60492-0075-1 - BAT

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 60492-0075
Requested NDC: 60492-0075-1
Package NDCs from labels: 60492-0075-1, 60492-0075-4, 60492-0075-2
Manufacturer: Emergent BioSolutions Canada Inc | BioReliance Corporation | Auburn University
Effective date: 2025-05-15
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
BAT - Emergent BioSolutions Canada Inc \| BioReliance Corporation \| Auburn University	Emergent BioSolutions Canada Inc \| BioReliance Corporation \| Auburn University	2025-05-15	PLASMA DERIVATIVE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
60492-0075-1	BAT	50 mL in 1 VIAL, GLASS	LIQUID	50	10
60492-0075-2	BAT	6 in 1 CARTON	LIQUID	6	10
60492-0075-4	BAT	1 in 1 CARTON	LIQUID	1	10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60492-0075	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [EMERGENT BIOSOLUTIONS CANADA INC.]	9	Current NDC, Legacy NDC, 3 package rows	20210622_9f3c4292-8773-4781-8264-d71c80d3eabd.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60492-0075-2	EA - Each	60492-0075	4a220678-dde9-4d44-b445-a95ef00baaf0	1	2024-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2	ACTIVE INGREDIENT	LE3J6I6DXP	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2	ACTIVE INGREDIENT	VSK09VP4HL	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2	ACTIVE INGREDIENT	X5I2P7E9TY	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2	ACTIVE INGREDIENT	30Y9N0SEBE	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2	ACTIVE INGREDIENT	T95649SUV7	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2	ACTIVE INGREDIENT	RJN8G983LQ	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2	ACTIVE INGREDIENT	943578J0XG	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2	ACTIVE MOIETY	LE3J6I6DXP	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2	ACTIVE MOIETY	VSK09VP4HL	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2	ACTIVE MOIETY	X5I2P7E9TY	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2	ACTIVE MOIETY	30Y9N0SEBE	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2	ACTIVE MOIETY	T95649SUV7	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2	ACTIVE MOIETY	RJN8G983LQ	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1
EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2	ACTIVE MOIETY	943578J0XG	BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rohto Max Strength	NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80	The Mentholatum Company	e4b49550-1ca3-4bd7-854d-409b53fa5e26	2026-08-20	Warnings	Exact identifier unii: 6OZP39ZG8H
Droptics Dry Eye Relief	CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80	Droptics LLC	29d7614b-f4b7-48e2-97c5-d1bff27731d2	2026-07-22	Warnings	Exact identifier unii: 6OZP39ZG8H
Rohto Cool Relief	NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80	The Mentholatum Company	dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30	2026-06-19	Warnings	Exact identifier unii: 6OZP39ZG8H
Refresh Optive Mega-3 PF	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80	Allergan, Inc.	326cb5d6-c784-404f-9a13-6d69262dda6e	2026-03-01	Warnings	Exact identifier unii: 6OZP39ZG8H
Refresh Digital PF	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80	Allergan, Inc.	97e83e68-6374-4df4-93f6-d707fc32748d	2022-11-28	Warnings	Exact identifier unii: 6OZP39ZG8H
Refresh Digital	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80	Allergan, Inc.	b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81	2022-11-28	Warnings	Exact identifier unii: 6OZP39ZG8H
REFRESH OPTIVE Advanced	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80	Allergan, Inc.	ebd0839e-2e1d-4e0e-986c-19f1f5c76358	2022-09-15	Warnings	Exact identifier unii: 6OZP39ZG8H
REFRESH OPTIVE Advanced	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80	Allergan, Inc.	aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0	2022-09-01	Warnings	Exact identifier unii: 6OZP39ZG8H
REFRESH Optive Mega-3	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80	Allergan, Inc.	c5f2b3f2-2071-45bd-a010-67f848bc0233	2022-06-30	Warnings	Exact identifier unii: 6OZP39ZG8H

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.